Surrozen banks $50M round to fuel its drive to the clinic with regenerative med platform
Two years after gaining a $33 million launch round for its regenerative medicine platform tech, the Bay Area biotech Surrozen has gone back to the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
